PlexusDx focuses on precision wellness by connecting biomarker insights with clinical context, helping you and your provider make informed decisions about which interventions align with your individual physiology rather than relying solely on population averages
BPC-157, KPV, TB-500, and MOTs-C to be Discussed at July PCAC Meeting As questions around peptides continue to grow, it is important for compounding pharmacists and healthcare professionals to stay informed about the evolving regulatory landscape
View Study Xu C, Sun L, Ren F, et al
BPC 157, or Body Protective Compound 157, is a peptide derived from a naturally occurring protein in the human body
Learn more Tirzepatide Therapy Dual GLP-1/GIP receptor agonist with up to 22.5% average weight loss in clinical trials
D51.x Is folate deficiency documented